Don’t miss out – Get your tickets early!

Join our upcoming FREE Webinar with Dr William (Bill) Richards (USA).

Join us to explore the intersection between psychedelic research and religious scholarship. In this webinar, you'll delve into the phenomenology of visionary and mystical states of consciousness, gaining insight into the transformative power of faith, trust, and suffering in psychological and spiritual growth. You'll also explore the shared wisdom of world religions and the cutting-edge frontiers where science meets the sacred, offering new perspectives on the profound mysteries of human experience.

Topic: The Awakening Dialogue between Psychedelic Research and Religious Scholarship

In this webinar you will learn:

Phenomenology of visionary and mystical states of consciousness
Appreciation for the power of faith and trust
Appreciation for the potential significance of suffering in psychological and spiritual development
Appreciation for the potential brotherhood of world religions
Appreciation for the frontiers of science where “sacred” knowledge is being encountered and reported.

EVENT DETAILS

DATE: 12th March 2025
TIME: 11:55pm (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTERS

Dr William (Bill) Richards (USA)
Psychologist

Dr William A. Richards (Bill), author of Sacred Knowledge: Psychedelics and Religious Experiences, is a Senior Advisor at Sunstone Therapies in Rockville, Maryland (USA), currently focused on the implementation of psychedelic-assisted therapy in palliative care.

Bill also is the co-founder of research at the Johns Hopkins Center for Psychedelic and Consciousness Research where he contributed to the rebirth of research with colleagues from 1999-2023, and teaches at the California Institute of Integral Studies and for MMA’s Certificate in Psychedelic-Assisted Therapies™. Bill’s graduate degrees encompass the psychology of religion, theology, comparative religion and clinical psychology.

Bill’s involvement with psychedelic research originated in Germany at the University of Göttingen in 1963. From 1967 to 1977, he pursued research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.